Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Dual Release Capsules Bioequivalence Study
CTR20244709Phase 4Completed
- Sponsor
- Tianjin Meihua Biomedical Technology
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diclofenac in acute arthritis, acute gout flare, arthritis, rheumatoid arthritis (RA), ankylosing spondylitis (AS), sponsored by Tianjin Meihua Biomedical Technology. Started Dec 2024; status: completed.
02
Drugs
diclofenac
03
Conditions
acute arthritisacute gout flarearthritisrheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20244709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244709.